Anti-inflammatory and angiostatic therapy in chemorefractory multisystem Langerhans' cell histiocytosis of adults.
Reichle
A
A
Vogt
Th
T
Kunz-Schughart
L
L
Bretschneider
Th
T
Bachthaler
M
M
Bross
K
K
Freund
S
S
Andreesen
R
R
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000031:analogs & derivatives*; D018432:Drug Resistance, Multiple; D054747:Histiocytic Sarcoma / Q000188:drug therapy*; D006801:Humans; D007783:Lactones / Q000008:administration & dosage; D008297:Male; D000077205:Pioglitazone; D013450:Sulfones / Q000008:administration & dosage; D045162:Thiazolidinediones / Q000008:administration & dosage
D020533:Angiogenesis Inhibitors; D000893:Anti-Inflammatory Agents; D007783:Lactones; D013450:Sulfones; D045162:Thiazolidinediones; C116926:rofecoxib; D003520:Cyclophosphamide; C003726:trofosfamide; D000077205:Pioglitazone